IRVINE, Calif., March 7, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that management is scheduled to make an investor presentation at the ROTH Annual Growth Stock Conference on Wednesday, March 14th, at 11:00 am Pacific Time. The conference is being held March 11-14th at the Ritz-Carlton in Dana Point, California.
